Patent Yard Sign in
Canadian application, no grantCanada

Novel antisense inhibition of rad51

CA 2362109 A1 · Owner: Zarling, David A. · Inventors: Reddy, Gurucharan; Zarling, David A.; Zeng, Hong

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Provided herein are methods for inhibiting cell proliferation in an individual comprising administering to the individual a composition comprising a Rad51 inhibitor. Also provided herein is a method for inhibiting the growth of a cell comprising administering to said cell a composition comprising a Rad51 inhibitor. Such methods can further include the step of providing radiation or DNA damaging agents after administration of said Rad51 inhibitor. Also described herein are methods which are performed in vivo and/or on cancerous cells.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 3, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 3, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 3, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 3, 2000
GrantedNo grant recorded
Term endedFebruary 3, 2020
Patent numberCA 2362109 A1
Classification (IPC)A61K31/70 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedFeb 3, 2000Term endedFeb 3, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.